Skip to main content

Table 2 Odds of receiving treatment in Indigenous compared to non-Indigenous (referent group) cancer patients: all cases and stratified by comorbidity score^

From: Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients

 

Adjusted OR* (95% CI)

Any treatment

0.46 (0.41, 0.63)

Stratified by:

comorbidity score 0

0.36 (0.23, 0.57)

 

comorbidity score 1

0.43 (0.23, 0.81)

 

comorbidity score 2+

0.73 (0.39, 1.34)

Curative treatment #

0.74 (0.56, 1.00)

Stratified by:

comorbidity score 0

0.76 (0.46, 1.03)

 

comorbidity score 1

0.55 (0.28, 1.09)

 

comorbidity score 2+

1.29 (0.65, 2.55)

Curative surgery #

0.82 (0.62,1.07)

Stratified by:

comorbidity score 0

0.68 (0.48, 0.97)

 

comorbidity score 1

0.86 (0.46, 1.60)

 

comorbidity score 2+

1.49 (0.74, 2.91)

Curative chemotherapy #

0.72 (0.53, 098)

Stratified by:

comorbidity score 0

0.79 (0.55, 1.13)

 

comorbidity score 1

0.62 (0.30, 1.28)

 

comorbidity score 2+

0.36 (0.12, 1.07)

Curative radiotherapy #

0.82 (0.63, 1.07)

Stratified by

comorbidity score 0

0.88 (0.64), 1.23)

 

comorbidity score 1

0.56 (0.29, 1.08)

 

comorbidity score 2+

0.66 (0.31, 1.42)

  1. *Adjusted for age, sex, remoteness, socioeconomic status, stage, comorbidity score.
  2. # metastatic cases excluded.
  3. ^Comorbidity Score: 0 (no known comorbidity), 1 (Charlson index of 1) or 2+ (Charlson index of 2 or more).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us